RxDoctor Payments Data

Benjamin Kachelman

Optometrist · Florence, ALNPI 1255442281

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Alcon accounts for 95.2% of it on its own, with 7 other manufacturers making up the rest. Among optometrist clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$100,914in general payments, 2019–2025

Across 327 payments — averaging $308.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$96K
  • Alcon Research LLC$4K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$260
  • Topcon Healthcare, Inc.$201
  • Coopervision Inc.$135
  • Bausch & Lomb Americas Inc.$119
  • plus $83 from 2 others
$1,280in research payments, 2019–2025

Across 1 payment — averaging $1280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Topcon Healthcare, Inc.$1K

What the payments were for

  • Consulting fees$29,31529%
  • Speaking & faculty fees$40,61940%
  • Travel & lodging$23,45723%
  • Food & beverage$7,5237%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,914 in reported general payments places this provider in the 95th percentile of 749 optometrist providers in Alabama.

See all optometrist providers in Alabama

Medicare billing

Part B allowed, 2024
$20,738
Medicare patients
166
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine11$11,551
TyrvayaVarenicline Tartrate11$6,012
Tobramycin-DexamethasoneTobramycin/Dexamethasone19$926
Latanoprost42$401
ErythromycinErythromycin Base17$179
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat11$155
Brimonidine Tartrate19$136

Paid to pharmacies, not to this prescriber.

Other optometrist in Florence

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →